微创体外循环与常规体外循环在微创主动脉瓣手术中的倾向评分匹配研究
本研究前瞻性收集288例首次孤立微创主动脉瓣置换术患者数据,比较微创体外循环(MiECC,n=102)与常规体外循环(c-ECC,n=186)的院内及1年结局,经倾向评分匹配后每组93例。结果显示MiECC组自体血液预充率更高、血红蛋白及血细胞比容更高、超快通道管理更常见、输血更少,且再次出血手术和术后房颤发生率更低,1年生存率无差异。结论认为MiECC安全有效,可促进快速康复。
要点
- MiECC组自体血液预充率82.4% vs 0%,P<0.001。
- MiECC组输血率32.7% vs 44%,P=0.04。
- MiECC组术后房颤30.1% vs 44.1%,P=0.034。
核心结论
- 在微创主动脉瓣置换术中,MiECC安全有效,相比c-ECC可促进超快通道管理并改善出血、输血和术后房颤结局。
研究设计与样本
- 前瞻性收集288例连续首次孤立微创主动脉瓣置换术患者数据,其中MiECC组102例、c-ECC组186例。
- 采用倾向评分匹配处理治疗选择偏倚,匹配后每组93例。
主要发现
- MiECC组自体血液预充率82.4% vs 0%,P<0.001。
- MiECC组最低血红蛋白9.3 vs 8.7 g/dl,P=0.021;最低血细胞比容27.9% vs 26.4%,P=0.023。
- MiECC组超快通道管理60.8% vs 26.9%,P<0.001;输血32.7% vs 44%,P=0.04。
- MiECC组再次出血手术0% vs 5.3%,P=0.031;术后房颤30.1% vs 44.1%,P=0.034。
- 院内死亡率MiECC组1.1% vs c-ECC组0%,P=0.5;1年生存率96.8% vs 97.5%,P=0.4。
临床怎么用
- 在微创主动脉瓣置换术中可考虑使用MiECC以促进超快通道管理并减少输血和术后房颤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The impact of minimally invasive extracorporeal circulation (MiECC) systems on the clinical outcomes of patients undergoing minimally invasive aortic valve replacement (MI-AVR) has still to be defined. This study compared in-hospital and 1 year outcomes of MI-AVR interventions using MiECC systems versus conventional extracorporeal circulation (c-ECC). METHODS: Data from 288 consecutive patients undergoing primary isolated MI-AVR using MiECC (n = 102) or c-ECC (n = 186) were prospectively collected. Treatment selection bias was addressed by the use of propensity score matching (MiECC vs c-ECC). After propensity score matching, 2 groups of 93 patients each were created. RESULTS: Compared with c-ECC, MiECC was associated with a higher rate of autologous priming (82.4% vs 0%; P < 0.001) and a greater nadir haemoglobin (9.3 vs 8.7 g/dl; P = 0.021) level and haematocrit (27.9% vs 26.4%; P = 0.023). Patients who had MiECC were more likely to receive ultra-fast-track management (60.8% vs 26.9%; P < 0.001) and less likely to receive blood transfusions (32.7% vs 44%; P = 0.04). The in-hospital mortality rate was 1.1% in the MiECC group and 0% in the c-ECC group (P = 0.5). Those in the MiECC group had reduced rates of bleeding requiring revision (0% vs 5.3%; P = 0.031) and postoperative atrial fibrillation (AF) (30.1% vs 44.1%; P = 0.034). The 1-year survival rate was 96.8% and 97.5% for MiECC and c-ECC patients, respectively (P = 0.4). CONCLUSIONS: MiECC systems were a safe and effective tool in patients who had MI-AVR. Compared with c-ECC, MiECC promotes ultra-fast-track management and provides better clinical outcomes as regards bleeding, blood transfusions and postoperative AF. Thus, by reducing surgical injury and promoting faster recovery, MiECC may further validate MI-AVR interventions.
引用
- Berretta P, Cefarelli M, Montecchiani L, et al. Minimally invasive versus standard extracorporeal circulation system in minimally invasive aortic valve surgery: a propensity score-matched study. Eur J Cardiothorac Surg. 2020. PMID: 31746980. doi:10.1093/ejcts/ezz318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。